Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2018-03-12 Regulatory Filings
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Completion of Innovate UK Grant Project
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated March 12, 2018. It announces the 'Completion of Innovate UK Grant Project' and details the funding received and future plans to publicize results. The presence of the RNS Number and the nature of the announcement (a specific operational update/achievement) strongly suggest this is a regulatory news service announcement. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/director change (MANG, DIRS), the most appropriate classification is the general regulatory filing category, RNS, as it is a standard announcement disseminated via the RNS system.
2018-03-12 English
Interim Results Statement
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Results Statement' for Physiomics PLC for the six-month period ended 31 December 2017. It contains detailed unaudited financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, and Statement of Changes in Equity. Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2018
2018-02-19 English
Contract Award
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces a 'Contract award' by Physiomics plc to a major pharmaceutical client, detailing the value and expected completion. This is a general regulatory announcement concerning business operations, not a specific financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, SHA, DIRS). Since it is a general regulatory announcement distributed via the RNS system and does not fit into the more specific categories, the appropriate classification is Regulatory Filings (RNS). The document length (3186 chars) is short, but the content is the announcement itself, not an announcement *about* another report, so RPA is less appropriate than RNS for this type of operational news.
2018-02-09 English
New Major Pharmaceutical Client
Regulatory Filings Classification · 1% confidence The document is very short (2771 characters) and announces a specific business event: 'Physiomics plc... is pleased to announce that it has been awarded a contract by a new major pharmaceutical client.' It is formatted as a regulatory news service (RNS) announcement, indicated by the 'RNS Number : 9521C' header and the closing line 'This information is provided by RNS'. This type of announcement, detailing a contract win or minor business update that doesn't fit specific financial reporting codes (like 10-K, ER, or CAP), is best classified under the general regulatory announcement category, RNS, as per the definitions and the 'MENU VS MEAL' rule suggesting short announcements default to RPA or RNS.
2018-01-26 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly contains the header 'RNS Number : 9537C' and is titled 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it uses the RNS distribution service, the content is specific to a major holding change, making 'MRQ' (Major Shareholding Notification) the most accurate classification over the general 'RNS' fallback.
2018-01-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 7648C' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (Regulatory News Service), the specific content dictates the classification should be 'MRQ' (Major Shareholding Notification) over the general 'RNS' fallback, as 'MRQ' is a defined, specific category for this exact type of filing.
2018-01-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.